DUPIXENT is now listed on the PBS for patients 12 years and older with severe atopic dermatitis who have had an inadequate response to topical corticosteroids.
Learn how to assess your patients for PBS eligibility
Sign up HERE
Attachment
DUPIXENT® Now PBS Listed for Atopic Dermatitis
More Latest News…
Menopause courses for health professionals
One of the key actions of the National Women’s Health Strategy 2020-2030 is to help women and their health care providers manage the effects of menopause by increasing menopause training among health professionals. The Senate Inquiry into issues related to menopause...
Information Night 13th May – The First Year of the Australasian Dermatology Registry
The Australasian Dermatology Registry (www.australasiandermatologyregistry.org.au) is hosting an online information evening “The First Year of the Australasian Dermatology Registry” for dermatologists and nurses on Tuesday 13th May 2025 at 7.30pm (AEDT). Join us for...
Webinar: Topical treatments for lentigo maligna: Integrating new research into clinical practice
Melanoma Institute Australia invites you to register for an educational webinar for Nurses, Dermatologists, Skin Cancer Doctors, GPs, Pharmacists and other healthcare professionals with an interest in skin cancer. Hosted by A/Prof Paul Fishburn (Skin Cancer GP) and...
Cutaneous Lymphoma International Nurses Network
